Cargando…
Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour
SIMPLE SUMMARY: Urinary bladder cancer (UBC) has a high recurrence rate, and biomarkers for different treatment strategies are highly needed. This study investigated the release of nanovesicles called exosomes from urinary bladder tissue from tumour-proximal sites as well as tumour-distant sites in...
Autores principales: | Eldh, Maria, Mints, Michael, Hiltbrunner, Stefanie, Ladjevardi, Sam, Alamdari, Farhood, Johansson, Markus, Jakubczyk, Tomasz, Veerman, Rosanne E., Winqvist, Ola, Sherif, Amir, Gabrielsson, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267924/ https://www.ncbi.nlm.nih.gov/pubmed/34209558 http://dx.doi.org/10.3390/cancers13133242 |
Ejemplares similares
-
Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
por: Hiltbrunner, Stefanie, et al.
Publicado: (2020) -
Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
por: Hiltbrunner, Stefanie, et al.
Publicado: (2016) -
Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo
por: Wahlund, Casper J. E., et al.
Publicado: (2017) -
Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
por: Alvaeus, Julia, et al.
Publicado: (2019) -
Potentiating antitumor immunity with αGC-loaded exosomes
por: Gehrmann, Ulf, et al.
Publicado: (2013)